regeneron.comRegeneron Pharmaceuticals: Delivering Life-transforming Medicines

") //-- ") //-- ") //-- Scientists Patients Medical Professionals Investors & Media Careers About Leadership Perspectives History Collaborations Industrial Operations Locations Science Pipeline Research Areas Antibodies Technology Regeneron Genetics Center Scientific Publications Medicines ARCALYST® (rilonacept) INJECTION DUPIXENT® (dupilumab) INJECTION EYLEA® (aflibercept) INJECTION KEVZARA® (sarilumab) INJECTION LIBTAYO® (cemiplimab-rwlc) INJECTION PRALUENT® (alirocumab) INJECTION Citizenship Science Education Science Competitions Sustainable Communities Supporting Patients Culture of Integrity Grants Investors & Media News Events & Presentations Stock Information Financial Information Corporate Governance FAQs Careers Scientists Patients Medical Professionals Contact Us Regeneron (NASDAQ: REGN) is a leading science and technology company delivering life-transforming medicines for serious diseases. Read on Our robust research and development engine allows us to discover therapies that could have a profound impact on patient health. Read on Our goal is to address serious medical conditions, across multiple and diverse therapeutic areas. Our FDA-approved medicines are only the beginning of our long-term commitment to solve the human body's most complex mysteries. Read on In addition to our work to invent new and needed medicines, we are focused on improving our world and operating with the highest standards of integrity. This commitment underscores our philosophy of “doing well by doing good,” every day. Read on About Leadership Perspectives History Collaborations Industrial Operations Locations Science Pipeline Research Areas Antibodies Technology Regeneron Genetics Center Scientific Publications Medicines ARCALYST® (rilonacept) INJECTION DUPIXENT® (dupilumab) INJECTION EYLEA® (aflibercept) INJECTION KEVZARA® (sarilumab) INJECTION LIBTAYO® (cemiplimab-rwlc) INJECTION PRALUENT® (alirocumab) INJECTION Citizenship Science Education Science Competitions Sustainable Communities Supporting Patients Culture of Integrity Grants Investors & Media News Events & Presentations Stock Information Financial Information Corporate Governance FAQs Careers Scientists Patients Medical Professionals Contact Us Make Great Medicine. And Then Do It Again and Again. Science As Limitless As Our Curiosity Humbled By Possibility Make Great Medicine. And Then Do It Again and Again. Science As Limitless As Our Curiosity Humbled By Possibility REGENERON NEWSROOM Follow us Check out our 2018 annual materials. The Responsibility Report and Annual Report are now online. Read our annual report and responsibility report Discover. Develop. Research. Repeat. Watch now REGENERON PERSPECTIVES Take a look behind the scenes and see what drives us with our on-going series of thought-provoking articles from Regeneron’s thought leaders. Featured perspective: A MILLION IS JUST THE BEGINNING By: JOHN OVERTON, PhD, VICE PRESIDENT, SEQUENCING AND LAB OPERATIONS PIONEERS IN ANTIBODY MEDICINE By: DREW MURPHY, PhD, EXECUTIVE VICE PRESIDENT, RESEARCH "For 30 years, our mission has been to use the power of science to bring new medicines to patients… over and over again." See our history LEARN HOW WE ARE REVOLUTIONIZING A NOTORIOUSLY DIFFICULT DRUG DEVELOPMENT PROCESS THE ROAD TO SEQUENCING OVER 800,000 PEOPLE STARTS HERE 20+ Our pipeline includes 20+ product candidates See What We’re Working On GROWING UP, I WANTED TO BE A SCIENTIST, LAB COAT AND ALL Visit our careers page SEE HOW WE’RE SUPPORTING YOUNG SCIENTISTS View our programs MEET LEN & GEORGE Get to know our leadership team FIND OUT WHY OUR SCIENTISTS DO WHAT THEY DO Watch their stories OUR COMMITMENT TO PATIENTS EXTENDS WELL BEYOND OUR LABS Learn about our support programs AS WE GROW, WE ARE MINDFUL OF OUR ENVIRONMENTAL FOOTPRINT EXPLORE OUR PUBLICATIONS LIBRARY About Leadership Perspectives History Collaborations Industrial Operations Locations Science Pipeline Research Areas Antibodies Technology Regeneron Genetics Center Scientific Publications Medicines ARCALYST® (rilonacept) INJECTION DUPIXENT® (dupilumab) INJECTION EYLEA® (aflibercept) INJECTION KEVZARA® (sarilumab) INJECTION LIBTAYO® (cemiplimab-rwlc) INJECTION PRALUENT® (alirocumab) INJECTION Citizenship Science Education Science Competitions Sustainable Communities Supporting Patients Culture of Integrity Grants Investors & Media News Events & Presentations Stock Information Financial Information Corporate Governance FAQs Careers Scientists Patients Medical Professionals Contact Us Terms of Use Privacy Policy Social Media Terms of Engagement Ireland Site Contact Us CAREERS Join our team and help turn science into life-changing medicine. Footer Column 1 Investors & Media News Events & Presentations Stock Information Financial Information Corporate Governance FAQs Patients Medical Professionals Scientists Footer Column 2 About Us Leadership Perspectives History Collaborations Industrial Operations Locations Science Pipeline Research Areas Antibodies Technology Regeneron Genetics Center Scientific Publications Footer Column 3 Medicines ARCALYST® (rilonacept) Injection DUPIXENT® (dupilumab) Injection EYLEA® (aflibercept) Injection KEVZARA® (sarilumab) Injection LIBTAYO® (cemiplimab-rwlc) Injection PRALUENT® (alirocumab) Injection Citizenship Science Education Science Competitions Sustainable Communities Supporting Patients Culture of Integrity Grants YOU ARE NOW LEAVING REGENERON.COM. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit. CANCEL CONTINUE YOU ARE NOW LEAVING REGENERON.COM TO VISIT ANOTHER REGENERON PHARMACEUTICALS WEBSITE. CANCEL CONTINUE CONFIRMED! Thank you for reaching out to us. We'll be in touch soon. The websites regeneron.com and regeneron.ie (the " Regeneron Sites ") use "cookies". Cookies are small text files which are automatically placed on your computer by the internet browser when you visit the Sites. A cookie can, amongst other things, track the web pages you visit and the options you use. Regeneron Pharmaceuticals, Inc. and its affiliates, Regeneron Ireland Unlimited Company and Regeneron UK Limited (together, " Regeneron ", " we ", " us " or " our ") use this data to make the Sites more user-friendly and efficient. We use Google Analytics cookie service to track and obtain reports on how visitors are using the Sites. The information obtained with this cookie, which includes the IP address of your computer, will be transmitted to and stored by Google on servers in the United States. Google may share that information with third parties if Google is obliged to do so by law or to the extent such third parties are processing this information on behalf of Google. Regeneron has no influence on such use. Yes, I accept cookies...